PEGFILGRASTIM-CBQV for Chemotherapy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where PEGFILGRASTIM-CBQV was used for Chemotherapy.
Most Reported Side Effects for PEGFILGRASTIM-CBQV
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Device malfunction | 356 | 48.6% | 1 | 3 |
| No adverse event | 265 | 36.2% | 0 | 0 |
| Death | 76 | 10.4% | 76 | 4 |
| Product dose omission issue | 61 | 8.3% | 3 | 5 |
| Product label confusion | 36 | 4.9% | 0 | 1 |
| Accidental exposure to product | 29 | 4.0% | 0 | 0 |
| Neutrophil count decreased | 18 | 2.5% | 0 | 9 |
| Bone pain | 17 | 2.3% | 0 | 2 |
| Device failure | 16 | 2.2% | 0 | 1 |
| Product packaging confusion | 16 | 2.2% | 0 | 0 |
| Product quality issue | 15 | 2.1% | 0 | 1 |
| Hospitalisation | 14 | 1.9% | 1 | 13 |
| Device leakage | 13 | 1.8% | 0 | 0 |
| Febrile neutropenia | 13 | 1.8% | 0 | 12 |
| Drug ineffective | 12 | 1.6% | 0 | 6 |
Other Indications for PEGFILGRASTIM-CBQV
Product used for unknown indication (409)
Infection prophylaxis (62)
Prophylaxis (57)
Neutropenia (19)
Pancreatic carcinoma (12)
Agranulocytosis (8)
Breast cancer (8)
Febrile neutropenia (8)
Breast cancer female (6)
Bone cancer (5)
Other Drugs Used for Chemotherapy
CYCLOPHOSPHAMIDE (3,372)
DOCETAXEL (2,134)
CARBOPLATIN (1,902)
DOXORUBICIN (1,756)
VINCRISTINE (1,743)
PACLITAXEL (1,425)
OXALIPLATIN (1,423)
METHOTREXATE (1,380)
CYTARABINE (1,355)
ETOPOSIDE (1,246)